| Shifting the landscape: Dominant C-terminal rare missense FOXL2 variants in non-syndromic primary ovarian failure etiology. | Shifting the landscape: Dominant C-terminal rare missense FOXL2 variants in non-syndromic primary ovarian failure etiology.
Jordan P, Verebi C, Hervé B, Perol S, Chakhtoura Z, Courtillot C, Bachelot A, Karila D, Renard C, Grouthier V, de la Croix SM, Bernard V, Fouveaut C, de la Perrière AB, Jonard-Catteau S, Touraine P, Plu-Bureau G, Dupont JM, Christin-Maitre S, Bienvenu T. | 10/2/2024 |
| FOXL2 and NR5A1 induce human fibroblasts into steroidogenic ovarian granulosa-like cells. | FOXL2 and NR5A1 induce human fibroblasts into steroidogenic ovarian granulosa-like cells.
Wen F, Ding Y, Wang M, Du J, Zhang S, Kee K., Free PMC Article | 05/24/2024 |
| Deletion of cis-regulatory Element in FOXL2 Promoter in a Chinese Family of Type II Blepharophimosis-ptosis-epicanthus Inversus Syndrome with Polydactyly. | Deletion of cis-regulatory Element in FOXL2 Promoter in a Chinese Family of Type II Blepharophimosis-ptosis-epicanthus Inversus Syndrome with Polydactyly.
Shen Q, Zhao X, Ji Y, Chai P., Free PMC Article | 02/8/2024 |
| FOXL2 Mutation Status in Sex Cord-stromal Tumors Cannot be Predicted by Morphology. | FOXL2 Mutation Status in Sex Cord-stromal Tumors Cannot be Predicted by Morphology.
Wessman S, Fuentes BB, Severin-Karlsson J, Westbom-Fremer S, Nistér M, Kokaraki G, Petta TB, Haglund F, Carlson JW. | 12/20/2023 |
| FOXL2: a gene central to ovarian function. | FOXL2: a gene central to ovarian function.
Mubeen A, Parra-Herran C. | 12/6/2023 |
| Expanded phenotypic spectrum of FOXL2 Variant c.672_701dup revealed by whole-exome sequencing in a rare blepharophimosis, ptosis, and epicanthus inversus syndrome family. | Expanded phenotypic spectrum of FOXL2 Variant c.672_701dup revealed by whole-exome sequencing in a rare blepharophimosis, ptosis, and epicanthus inversus syndrome family.
Lin ZB, Chen ZJ, Yang H, Ding XR, Li J, Pan AP, Sun HS, Yu AY, Chen SH., Free PMC Article | 11/28/2023 |
| ERK1/2-SOX9/FOXL2 axis regulates ovarian steroidogenesis and favors the follicular-luteal transition. | ERK1/2-SOX9/FOXL2 axis regulates ovarian steroidogenesis and favors the follicular-luteal transition.
Baddela VS, Michaelis M, Tao X, Koczan D, Vanselow J., Free PMC Article | 08/4/2023 |
| Incidental FOXL2 mutated adult granulosa cell tumour of the ovary with thecoma-like foci. | Incidental FOXL2 mutated adult granulosa cell tumour of the ovary with thecoma-like foci.
Fischer AK, Schömig-Markiefka B, Heydt C, Ratiu D, Mallmann P, Meinel J, Büttner R, Schmidt D, Quaas A., Free PMC Article | 07/10/2023 |
| The Genetics and Biology of FOXL2. | The Genetics and Biology of FOXL2.
Tucker EJ. | 11/12/2022 |
| Whole-exome sequencing identifies FOXL2, FOXA2 and FOXA3 as candidate genes for monogenic congenital anomalies of the kidneys and urinary tract. | Whole-exome sequencing identifies FOXL2, FOXA2 and FOXA3 as candidate genes for monogenic congenital anomalies of the kidneys and urinary tract.
Zheng B, Seltzsam S, Wang C, Schierbaum L, Schneider S, Wu CW, Dai R, Connaughton DM, Nakayama M, Mann N, Stajic N, Mane S, Bauer SB, Tasic V, Nam HJ, Shril S, Hildebrandt F., Free PMC Article | 10/1/2022 |
| FOXL2 and FOXA1 cooperatively assemble on the TP53 promoter in alternative dimer configurations. | FOXL2 and FOXA1 cooperatively assemble on the TP53 promoter in alternative dimer configurations.
Choi Y, Luo Y, Lee S, Jin H, Yoon HJ, Hahn Y, Bae J, Lee HH., Free PMC Article | 09/3/2022 |
| A Novel Forkhead Box L2 Missense Mutation, c.1068G>C, in a Chinese Family With Blepharophimosis/Ptosis/ Epicanthus Inversus Syndrome. | A Novel Forkhead Box L2 Missense Mutation, c.1068G>C, in a Chinese Family With Blepharophimosis/Ptosis/ Epicanthus Inversus Syndrome.
Wang S, Ge S, Zhuang A. | 06/25/2022 |
| Long-Range Regulation of Key Sex Determination Genes. | Long-Range Regulation of Key Sex Determination Genes.
Migale R, Neumann M, Lovell-Badge R. | 03/19/2022 |
| Adult-type granulosa cell tumor of the ovary: a FOXL2-centric disease. | Adult-type granulosa cell tumor of the ovary: a FOXL2-centric disease.
Pilsworth JA, Cochrane DR, Neilson SJ, Moussavi BH, Lai D, Munzur AD, Senz J, Wang YK, Zareian S, Bashashati A, Wong A, Keul J, Staebler A, van Meurs HS, Horlings HM, Kommoss S, Kommoss F, Oliva E, Färkkilä AE, Gilks B, Huntsman DG., Free PMC Article | 01/29/2022 |
| FOXL2 in adult-type granulosa cell tumour of the ovary: oncogene or tumour suppressor gene? | FOXL2 in adult-type granulosa cell tumour of the ovary: oncogene or tumour suppressor gene?
Pilsworth JA, Todeschini AL, Neilson SJ, Cochrane DR, Lai D, Anttonen M, Heikinheimo M, Huntsman DG, Veitia RA. | 01/1/2022 |
| FOXL2 and TERT promoter mutation detection in circulating tumor DNA of adult granulosa cell tumors as biomarker for disease monitoring. | FOXL2 and TERT promoter mutation detection in circulating tumor DNA of adult granulosa cell tumors as biomarker for disease monitoring.
Groeneweg JW, Roze JF, Peters EDJ, Sereno F, Brink AGJ, Paijens ST, Nijman HW, van Meurs HS, van Lonkhuijzen LRCW, Piek JMJ, Lok CAR, Monroe GR, van Haaften GW, Zweemer RP. | 12/4/2021 |
| Immunohistochemical Characterization of 120 Testicular Sex Cord-Stromal Tumors With an Emphasis on the Diagnostic Utility of SOX9, FOXL2, and SF-1. | Immunohistochemical Characterization of 120 Testicular Sex Cord-Stromal Tumors With an Emphasis on the Diagnostic Utility of SOX9, FOXL2, and SF-1.
Lau HD, Kao CS, Williamson SR, Cheng L, Ulbright TM, Idrees MT. | 10/9/2021 |
| The role of FOXL2, SOX9, and beta-catenin expression and DICER1 mutation in differentiating sex cord tumor with annular tubules from other sex cord tumors of the ovary. | The role of FOXL2, SOX9, and β-catenin expression and DICER1 mutation in differentiating sex cord tumor with annular tubules from other sex cord tumors of the ovary.
Onder S, Hurdogan O, Bayram A, Yilmaz I, Sozen H, Yavuz E. | 09/11/2021 |
| The Genetic and Clinical Features of FOXL2-Related Blepharophimosis, Ptosis and Epicanthus Inversus Syndrome. | The Genetic and Clinical Features of FOXL2-Related Blepharophimosis, Ptosis and Epicanthus Inversus Syndrome.
Méjécase C, Nigam C, Moosajee M, Bladen JC., Free PMC Article | 08/7/2021 |
| Evaluation of molecular analysis in challenging ovarian sex cord-stromal tumours: a review of 50 cases. | Evaluation of molecular analysis in challenging ovarian sex cord-stromal tumours: a review of 50 cases.
Stewart CJR, Amanuel B, De Kock L, Apellaniz-Ruiz M, Carrello A, Giardina T, Grieu-Iacopetta F, Thomas MA, Foulkes WD. | 07/31/2021 |
| FOXL2 expression might be a novel prognostic biomarker in patients with laryngeal squamous cell carcinoma. | FOXL2 expression might be a novel prognostic biomarker in patients with laryngeal squamous cell carcinoma.
Ge J, Jiang L, Tian Y, Zheng M, Huang M, Li J., Free PMC Article | 06/26/2021 |
| Ovarian granulosa cell tumor characterization identifies FOXL2 as an immunotherapeutic target. | Ovarian granulosa cell tumor characterization identifies FOXL2 as an immunotherapeutic target.
Pierini S, Tanyi JL, Simpkins F, George E, Uribe-Herranz M, Drapkin R, Burger R, Morgan MA, Facciabene A., Free PMC Article | 06/12/2021 |
| Hypopituitarism in Patients with Blepharophimosis and FOXL2 Mutations. | Hypopituitarism in Patients with Blepharophimosis and FOXL2 Mutations.
Castets S, Roucher-Boulez F, Saveanu A, Mallet-Motak D, Chabre O, Amati-Bonneau P, Bonneau D, Girardin C, Morel Y, Villanueva C, Brue T, Reynaud R, Nicolino M. | 04/24/2021 |
| An alternative miRISC targets a cancer-associated coding sequence mutation in FOXL2. | An alternative miRISC targets a cancer-associated coding sequence mutation in FOXL2.
Shin E, Jin H, Suh DS, Luo Y, Ha HJ, Kim TH, Hahn Y, Hyun S, Lee K, Bae J., Free PMC Article | 04/17/2021 |
| Rare DICER1 and Absent FOXL2 Mutations Characterize Ovarian Juvenile Granulosa Cell Tumors. | Rare DICER1 and Absent FOXL2 Mutations Characterize Ovarian Juvenile Granulosa Cell Tumors.
Baillard P, Genestie C, Croce S, Descotes F, Rouleau E, Treilleux I, Gouy S, Morice P, Ray-Coquard I, McCluggage WG, Devouassoux-Shisheboran M. | 02/27/2021 |